Remedy Meds medication cost examples FDA Status of Compounded GLP-1 Medications As of June 2025, the FDA has removed both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) from its drug shortage list
Contact us today to schedule a consultation and discover how B12 Vitamin Injections can boost your health and, in turn, your energy and confidence
Compounding is meant to be used only in narrow circumstances, such as during an official drug shortage or when a patient cannot take a branded medication for specific medical reasons
Common semaglutide concentrations: 1 mg/mL, 2.5 mg/mL, 5 mg/mL Common tirzepatide concentrations: 5 mg/mL, 10 mg/mL, 15 mg/mL, 20 mg/mL A 5 mg dose of tirzepatide from a 10 mg/mL vial requires 50 units